Table 2

 Patient disposition

Fixed combination latanoprost/timolol, n (%)Unfixed combination brimonidine/timolol, n (%)
IOP, intraocular pressure.
Total randomised166 (100.0)168 (100.0)
Completed study156 (94.0)139 (82.7)
Withdrew from study10 (6.0)29 (17.3)
Reasons for withdrawal
    Adverse event3 (1.8)18 (10.7)
    Uncontrolled IOP3 (1.8)3 (1.8)
    Protocol violation3 (1.8)2 (1.2)
    Consent withdrawn0 (0.0)5 (3.0)
    Lost to follow up1 (0.6)0 (0.0)
    Other0 (0.0)1 (0.6)